National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data & Analytics
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Consumer Assessment of Healthcare Providers and Systems (CAHPS®) Program
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- National Healthcare Quality and Disparities Report Data Tools
- AHRQ Quality Indicator Tools for Data Analytics
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Access to Care (34)
- Adverse Drug Events (ADE) (7)
- Adverse Events (16)
- Alcohol Use (1)
- Ambulatory Care and Surgery (17)
- Antibiotics (5)
- Antimicrobial Stewardship (6)
- Arthritis (7)
- Asthma (5)
- Autism (2)
- Back Health and Pain (4)
- Behavioral Health (29)
- Blood Clots (1)
- Blood Pressure (3)
- Blood Thinners (3)
- Brain Injury (2)
- Cancer (56)
- Cancer: Breast Cancer (10)
- Cancer: Cervical Cancer (1)
- Cancer: Colorectal Cancer (5)
- Cancer: Lung Cancer (5)
- Cancer: Ovarian Cancer (1)
- Cancer: Prostate Cancer (9)
- Cancer: Skin Cancer (2)
- Cardiovascular Conditions (29)
- Care Coordination (4)
- Caregiving (9)
- Care Management (7)
- Catheter-Associated Urinary Tract Infection (CAUTI) (2)
- Central Line-Associated Bloodstream Infections (CLABSI) (2)
- Children's Health Insurance Program (CHIP) (2)
- Children/Adolescents (56)
- Chronic Conditions (40)
- Clinical Decision Support (CDS) (4)
- Clinician-Patient Communication (4)
- Clostridium difficile Infections (1)
- Colonoscopy (4)
- Communication (3)
- Community-Acquired Infections (1)
- Community-Based Practice (4)
- Comparative Effectiveness (9)
- Consumer Assessment of Healthcare Providers and Systems (CAHPS) (1)
- COVID-19 (10)
- Critical Care (10)
- Data (6)
- Dementia (6)
- Dental and Oral Health (5)
- Depression (4)
- Diabetes (20)
- Diagnostic Safety and Quality (9)
- Dialysis (3)
- Digestive Disease and Health (6)
- Disabilities (3)
- Disparities (13)
- Domestic Violence (1)
- Education (3)
- Education: Patient and Caregiver (3)
- Elderly (53)
- Electronic Health Records (EHRs) (2)
- Electronic Prescribing (E-Prescribing) (1)
- Emergency Department (16)
- Emergency Medical Services (EMS) (6)
- Evidence-Based Practice (9)
- Eye Disease and Health (7)
- Falls (3)
- Family Health and History (2)
- Genetics (4)
- Guidelines (5)
- Healthcare-Associated Infections (HAIs) (15)
- Healthcare Cost and Utilization Project (HCUP) (57)
- (-) Healthcare Costs (793)
- Healthcare Delivery (25)
- Healthcare Utilization (52)
- Health Information Technology (HIT) (13)
- Health Insurance (138)
- Health Promotion (2)
- Health Services Research (HSR) (25)
- Health Status (8)
- Health Systems (7)
- Heart Disease and Health (14)
- Hepatitis (3)
- Home Healthcare (7)
- Hospital Discharge (8)
- Hospitalization (53)
- Hospital Readmissions (12)
- Hospitals (82)
- Human Immunodeficiency Virus (HIV) (17)
- Imaging (5)
- Implementation (2)
- Infectious Diseases (17)
- Influenza (7)
- Injuries and Wounds (9)
- Inpatient Care (14)
- Intensive Care Unit (ICU) (7)
- Kidney Disease and Health (11)
- Labor and Delivery (5)
- Lifestyle Changes (3)
- Long-Term Care (11)
- Low-Income (22)
- Maternal Care (5)
- Medicaid (50)
- Medical Devices (4)
- Medical Errors (2)
- Medical Expenditure Panel Survey (MEPS) (70)
- Medical Liability (1)
- Medicare (159)
- Medication (108)
- Medication: Safety (1)
- Men's Health (3)
- Methicillin-Resistant Staphylococcus aureus (MRSA) (1)
- Mortality (15)
- Neurological Disorders (12)
- Newborns/Infants (8)
- Nursing (4)
- Nursing Homes (14)
- Nutrition (4)
- Obesity (13)
- Obesity: Weight Management (5)
- Opioids (9)
- Organizational Change (1)
- Orthopedics (11)
- Osteoporosis (1)
- Outcomes (26)
- Pain (4)
- Palliative Care (8)
- Patient-Centered Healthcare (13)
- Patient-Centered Outcomes Research (31)
- Patient Adherence/Compliance (14)
- Patient and Family Engagement (3)
- Patient Experience (2)
- Patient Safety (17)
- Patient Self-Management (2)
- Payment (75)
- Pneumonia (4)
- Policy (80)
- Practice Patterns (7)
- Pregnancy (12)
- Pressure Ulcers (2)
- Prevention (31)
- Primary Care (24)
- Primary Care: Models of Care (4)
- Provider (2)
- Provider: Clinician (1)
- Provider: Health Personnel (2)
- Provider: Nurse (1)
- Provider: Pharmacist (2)
- Provider: Physician (5)
- Provider Performance (9)
- Public Health (12)
- Public Reporting (2)
- Quality Improvement (14)
- Quality Indicators (QIs) (2)
- Quality Measures (1)
- Quality of Care (46)
- Quality of Life (16)
- Racial and Ethnic Minorities (13)
- Registries (3)
- Research Methodologies (4)
- Respiratory Conditions (14)
- Risk (10)
- Rural/Inner-City Residents (2)
- Rural Health (10)
- Screening (24)
- Sepsis (4)
- Sexual Health (7)
- Shared Decision Making (22)
- Sickle Cell Disease (1)
- Skin Conditions (12)
- Sleep Problems (3)
- Social Determinants of Health (11)
- Stress (2)
- Stroke (4)
- Substance Abuse (12)
- Surgery (101)
- Teams (2)
- Telehealth (7)
- Tobacco Use (1)
- Tobacco Use: Smoking Cessation (1)
- Tools & Toolkits (1)
- Training (1)
- Transitions of Care (4)
- Transplantation (3)
- Trauma (6)
- Treatments (14)
- U.S. Preventive Services Task Force (USPSTF) (1)
- Uninsured (10)
- Urban Health (2)
- Urinary Tract Infection (UTI) (3)
- Vaccination (30)
- Vulnerable Populations (7)
- Web-Based (1)
- Women (22)
- Workforce (6)
- Young Adults (3)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 25 of 793 Research Studies DisplayedBartsch SM, Weatherwax C, Martinez MF
Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
This study examined the question when and how often nursing homes should test staff for COVID-19 and how this may change as severe acute respiratory coronavirus virus 2 (SARS-CoV-2) evolves. In winter 2023-2024, when the SARS-CoV-2 omicron variant was prevalent, symptom-based antigen testing averted 4.5 COVID-19 cases compared to no testing, saving $191 in direct medical costs. Testing implementation costs far outweighed these savings, resulting in net costs of $990 from the CMS perspective, $1,545 from the third-party payer perspective, and $57,155 from the societal perspective. Testing did not return sufficient positive health effects to make it cost-effective, but it exceeded this threshold in ≥59% of simulation trials. However, if conditions changed to make a severe outcome risk ≥3 times higher than that of current omicron variants, all antigen testing strategies became cost-effective (≤$31,906 per QALY) or cost saving (saving ≤$18,372).
AHRQ-funded; HS028165.
Citation: Bartsch SM, Weatherwax C, Martinez MF .
Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
Infect Control Hosp Epidemiol 2024 Jun; 45(6):754-61. doi: 10.1017/ice.2024.9..
Keywords: COVID-19, Healthcare Costs, Nursing Homes, Diagnostic Safety and Quality
Ilkhani S, Naus AE, Pinkes N
The invisible scars: unseen financial complications worsen every aspect of long-term health in trauma survivors.
This study investigated financial toxicity (FT) among trauma survivors, aiming to understand its prevalence, risk factors, and impact on long-term outcomes. The researchers interviewed adult trauma patients with an Injury Severity Score of 9 or higher from Level I trauma centers, 6 to 14 months after discharge. FT was defined as experiencing income loss, lack of care, newly applied or qualified governmental assistance, new financial problems, or work loss due to injury. The study found that 44% of the 577 participants experienced some form of FT. Protective factors against FT included older age and stronger social support networks. Conversely, having two or more comorbidities, lower education levels, and injuries from road accidents or intentional causes were associated with higher FT risk. Notably, injury severity, sex, and single-family household status did not show significant relationships with FT. Patients experiencing FT demonstrated worse outcomes across all health domains measured by the Patient Reported Outcome Measure Index System (PROMIS). A negative linear relationship was observed between FT severity and both mental and physical health scores.
AHRQ-funded; HS028672.
Citation: Ilkhani S, Naus AE, Pinkes N .
The invisible scars: unseen financial complications worsen every aspect of long-term health in trauma survivors.
J Trauma Acute Care Surg 2024 Jun; 96(6):893-900. doi: 10.1097/ta.0000000000004247..
Keywords: Trauma, Healthcare Costs, Health Status, Injuries and Wounds
Cohen DJ, Totten AM, Phillips RL
Measuring primary care spending in the US by state.
This study analyzed methods of states’ estimates of primary care spending that was discussed in AHRQ Technical Brief No. 44. Ten states were analyzed, with Maine, Utah, Virginia, and Washington using different narrow definitions of primary care. Maryland, Maine, Virginia, Utah, and Washington used broad definitions of primary care while Connecticut, Massachusetts, Vermont, and Colorado not defining primary care as narrow or broad. All ten states estimated primary care spending by payer type and for commercial payers. Some provided estimates for Medicaid, Medicare Advantage, and Medicare Fee-for-Service. The authors identified sizable differences in state primary care spending estimates. They could not determine if spending differs across states, time, or in response to policies because there is no standard measure of measurement. They recommend steps policymakers can take towards standardizing those estimates.
AHRQ-funded; 75Q80120D00006.
Citation: Cohen DJ, Totten AM, Phillips RL .
Measuring primary care spending in the US by state.
JAMA Health Forum 2024 May 3; 5(5):e240913. doi: 10.1001/jamahealthforum.2024.0913..
Keywords: Primary Care, Healthcare Costs
Shi M, M
Monitoring for waste: evidence from Medicare audits.
This paper examined tradeoffs of monitoring for wasteful public spending. The author studied a large Medicare program that monitored for unnecessary healthcare spending and considered its effect on government savings, provider behavior, and patient health. Findings indicated that every Medicare dollar spent on monitoring generated $24-29 in government savings; the majority of savings stemmed from the deterrence of future care. No evidence was found that the health of the marginal patient is harmed, indicating that monitoring primarily deters low-value care. The author concluded that while monitoring increased provider administrative costs, these costs were incurred upfront and included investments in technology to assess the medical necessity of care.
AHRQ-funded; HS027715.
Citation: Shi M, M .
Monitoring for waste: evidence from Medicare audits.
Q J Econ 2024 May; 139(2):993-1049. doi: 10.1093/qje/qjad049..
Keywords: Medicare, Healthcare Costs, Healthcare Cost and Utilization Project (HCUP)
Hider AM, Gomez-Rexrode AE, Agius J
Association of bundled payments with spending, utilization, and quality for surgical conditions: a scoping review.
This scoping review assessed the body of literature examining episode-based bundled payment models effect on health care spending, utilization, and quality of care for surgical conditions. Bundled payment models let hospitals receive financial incentives to reduce spending on care provided to patients during a predefined clinical episode. The review queried four databases from inception through September 27, 2021. A total of 879 unique articles were found, of which 28 met final inclusion criteria. Of these studies, 23 out of 28 evaluated the impact of voluntary bundled payments in orthopedic surgery and found that bundled payments are associated with reduced spending on total care episodes, attributed primarily to decreases in post-acute care spending. This reduced spending did not worsen clinical outcomes (e.g., readmissions, complications, and mortality). Evidence for non-orthopedic surgery bundled payments remains limited.
AHRQ-funded; HS028606.
Citation: Hider AM, Gomez-Rexrode AE, Agius J .
Association of bundled payments with spending, utilization, and quality for surgical conditions: a scoping review.
Am J Surg 2024 Mar; 229:83-91. doi: 10.1016/j.amjsurg.2023.12.009.
Keywords: Surgery, Payment, Healthcare Costs
King CA, Beetham T, Smith N
Adolescent residential addiction treatment in the US: uneven access, waitlists, and high costs.
This study examined adolescent residential addiction treatment facilities in the United States, and their accessibility and cost. The authors used the Substance Abuse and Mental Health Services Administration's treatment locator and search engine advertising data to identify 160 residential addiction treatment facilities that treated adolescents with opioid use disorder as of December 2022. They called facilities while role-playing as the aunt or uncle of a sixteen-year-old child with a recent nonfatal overdose to inquire about policies and costs. A little over half (54.5%) had a bed immediately available. The mean wait time for a bed was 28.4 days among sites with a waitlist. Of the facilities that provided cost information, the mean cost of treatment per day was $878, with daily costs among for-profit facilities triple of nonprofit facilities. Half of facilities required up-front payments by noninsured patients, with a mean up-front cost of $28,731. They were unable to identify any facilities for adolescents in ten states or Washington, D.C.
AHRQ-funded; HS017589.
Citation: King CA, Beetham T, Smith N .
Adolescent residential addiction treatment in the US: uneven access, waitlists, and high costs.
Health Aff 2024 Jan; 43(1):64-71. doi: 10.1377/hlthaff.2023.00777..
Keywords: Children/Adolescents, Substance Abuse, Healthcare Costs, Access to Care
Moniz MH, Stout MJ, Kolenic GE
Association of childbirth with medical debt.
The purpose of this study was to assess the relationship between childbirth and having medical debt in collections and explored variations by neighborhood socioeconomic status. The study found that among a statewide cohort (n=26,717) of commercially insured pregnant and postpartum adults, having medical debt in collections was more likely among postpartum individuals compared with pregnant individuals and those in lowest-income neighborhoods compared with all others. Postpartum adults in the lowest-income neighborhoods also had the greatest predicted probabilities of having medical debt in collections, followed by pregnant adults in the lowest-income neighborhoods, followed by all other postpartum and pregnant adults.
AHRQ-funded; HS025465; HS028672; HS027788.
Citation: Moniz MH, Stout MJ, Kolenic GE .
Association of childbirth with medical debt.
Obstet Gynecol 2024 Jan; 143(1):11-13. doi: 10.1097/aog.0000000000005381..
Keywords: Maternal Care, Women, Healthcare Costs
Meiselbach MK, Bai G, Anderson GF
Charges of COVID-19 diagnostic testing and antibody testing across facility types and states.
The authors discuss the practice of high charges for COVID-19 testing by some healthcare providers, with the charges for COVID-19 testing having important implications for uninsured patients, out-of-network services, and other payers without negotiating power. The purpose of this study was to examine the charges for the most commonly performed COVID-19 diagnostic test and antibody test across facility types and states. The study found that for COVID-19 diagnostic testing, the mean, median, and standard deviations of charges were $144.06, $100.00, and $162.18. The most common facility type was independent laboratories (performing 49.7% of all tests), with an average charge of $140.41, followed by hospital outpatient settings (performing 34.5% of all tests), with an average charge of $168.87. For antibody testing, the mean, median, and standard deviations of charges were $63.93, $55.00, and $48.92. Independent laboratories performed 97.2% of all tests, with an average charge of $62.30. In sum, 8.0% of diagnostic testing services and 14.0% of antibody testing claims were charged one standard deviation above the mean ($306.24 for diagnostic testing and $112.85 for antibody testing). The state average testing charges ranged between $64.98 (UT) and $505.65 (DC) for diagnostic testing, and $45.85 (NY) and $195.41 (NM) for antibody testing. AR, LA, MO, and NM had high average charges for both tests. GA, KS, MA, MD, NC, NV, and OK had low charges for both tests. No statistically significant association was found between testing charges and state-level testing rates, infection rates, or mortality rates.
AHRQ-funded; HS000029.
Citation: Meiselbach MK, Bai G, Anderson GF .
Charges of COVID-19 diagnostic testing and antibody testing across facility types and states.
J Gen Intern Med 2023 Dec; 38(16):3640-43. doi: 10.1007/s11606-020-06198-y..
Keywords: COVID-19, Diagnostic Safety and Quality, Healthcare Costs
Scott JW, Knowlton LM, Murphy P
Financial toxicity after trauma and acute care surgery: from understanding to action.
The negative impact of major injuries and surgical emergencies on patients’ long-term financial wellbeing is a factor that is often overlooked by clinicians and researchers. The concept of financial toxicity includes the objective financial repercussions of illness and medical care and also subjective financial concerns of patients. The purpose of this review was to 1) provide a conceptual overview of financial toxicity after trauma or emergency surgery, 2) outline what is known about the long-term economic outcomes among trauma and emergency surgery patients, 3) examine the relationship between financial toxicity and long-term physical and mental health outcomes, 4) describe policies and programs that may mitigate financial toxicity, and 5) identify the current knowledge gaps and urgent next steps for clinicians and researchers engaged in this area of work.
AHRQ-funded; HS028672.
Citation: Scott JW, Knowlton LM, Murphy P .
Financial toxicity after trauma and acute care surgery: from understanding to action.
J Trauma Acute Care Surg 2023 Nov 1; 95(5):800-05. doi: 10.1097/ta.0000000000003979..
Keywords: Healthcare Costs, Trauma, Surgery
Bernard DM, Selden TM, Fang Z
AHRQ Author: Bernard
The joint distribution of high out-of-pocket burdens, medical debt, and financial barriers to needed care.
This AHRQ-authored paper examined the joint distribution of three financial problems related to healthcare: high out-of-pocket burdens, medical debt, and financial barriers to needed care. The authors applied relatively strict definitions of financial problems to data from the 2018-2019 MEPS and found that 27% of nonsenior adults lived in families with at least one of the three financial strains assessed. The percentage of participants who faced more broadly defined financial problems was 45.5%. This prevalence varied across sociodemographic characteristics, families' health care needs, insurance coverage, and financial resources.
AHRQ-authored.
Citation: Bernard DM, Selden TM, Fang Z .
The joint distribution of high out-of-pocket burdens, medical debt, and financial barriers to needed care.
Health Aff 2023 Nov; 42(11):1517-26. doi: 10.1377/hlthaff.2023.00604..
Keywords: Medical Expenditure Panel Survey (MEPS), Healthcare Costs, Access to Care, Health Insurance
Hughes PM, Ramage M, Gigli KH
Assessing the cost-effectiveness of removing supervision requirements for nurse practitioners prescribing buprenorphine for opioid use disorder.
The purpose of this study was to evaluate the cost-effectiveness of full practice authority relative to restricted scope of practice for nurse practitioners (NPs) who intend to prescribe buprenorphine for opioid use disorder before implementation of the Mainstreaming Addiction Treatment Act and the Medication Access and Training Expansion Act (MAT/MATE) Acts. The study also examined scenarios modeling various implementations of MAT/MATE. A simulated cohort of 10,000 NPs went through a decision tree model with a 1-year time horizon. The results indicated that adoption of full practice authority for NPs may be cost-effective for increasing the available workforce for substance use treatment and for increasing the number of patients receiving buprenorphine.
AHRQ-funded; HS000032.
Citation: Hughes PM, Ramage M, Gigli KH .
Assessing the cost-effectiveness of removing supervision requirements for nurse practitioners prescribing buprenorphine for opioid use disorder.
J Nurs Regul 2023 Oct; 14(3):44-54. doi: 10.1016/S2155-8256(23)00112-6..
Keywords: Opioids, Substance Abuse, Behavioral Health, Provider: Nurse, Policy, Healthcare Costs
Mullens CL, Lussiez A, Scott JW
Association of health professional shortage area hospital designation with surgical outcomes and expenditures among Medicare beneficiaries.
This study’s objective was to compare surgical outcomes and expenditures at hospitals located in Health Professional Shortage Areas to nonshortage area designated hospitals among Medicare beneficiaries. This cross-sectional retrospective study used data from 842,787 Medicare beneficiary patient admissions to hospitals with and without Health Professional Shortage Area designations for common operations including appendectomy, cholecystectomy, colectomy, and hernia repair from 2014 to 2018. Primary outcomes measures were 30-day mortality, hospital readmissions, and 30-day surgical episode payments. Patients (mean age=75.6 years, males=44.4%) undergoing common surgical procedures in shortage area hospitals were less likely to be White (84.6% vs 88.4%) and less likely to have≥2 Elixhauser comorbidities (75.5% vs 78.2%). Patients undergoing surgery at Health Professional Shortage Area hospitals had lower risk-adjusted rates of 30-day mortality (6.05% vs 6.69%) and readmission (14.99% vs 15.74%). Medicare expenditures at Health Professional Shortage Area hospitals were also lower than nonshortage designated hospitals ($28,517 vs $29,685).
AHRQ-funded; HS028606; HS028672.
Citation: Mullens CL, Lussiez A, Scott JW .
Association of health professional shortage area hospital designation with surgical outcomes and expenditures among Medicare beneficiaries.
Ann Surg 2023 Oct 1; 278(4):e733-e39. doi: 10.1097/sla.0000000000005762..
Keywords: Hospitals, Surgery, Medicare, Healthcare Costs, Workforce, Outcomes
Scott JW, Neiman PU, Scott KW
High deductibles are associated with severe disease, catastrophic out-of-pocket payments for emergency surgical conditions.
This retrospective analysis of claims data examined the association of a high-deductible health insurance plan (HDHP) with severe disease and catastrophic out-of-pocket payments for emergency surgical conditions (e.g., appendicitis, cholecystitis, diverticulitis, and intestinal obstruction). Primary outcome was disease severity at presentation-determined using ICD-10-CM diagnoses codes and based on validated measures of anatomic severity (e.g., perforation, abscess, diffuse peritonitis). The secondary outcome was catastrophic out-of-pocket spending, defined by the World Health Organization as out-of-pocket spending >10% of annual income. Among 43,516 patients [mean age 48.4 years; 51% female], 41% were enrolled in HDHPs. Despite being younger, healthier, wealthier, and more educated, HDHP enrollees were more likely to present with more severe disease (28.5% vs 21.3%); even after adjusting for relevant demographics. HDHP enrollees were also more likely to incur 30-day out-of-pocket spending that exceeded 10% of annual income (20.8% vs 6.4%).
AHRQ-funded; HS027788; HS028672.
Citation: Scott JW, Neiman PU, Scott KW .
High deductibles are associated with severe disease, catastrophic out-of-pocket payments for emergency surgical conditions.
Ann Surg 2023 Oct 1; 278(4):e667-e74. doi: 10.1097/sla.0000000000005819..
Keywords: Health Insurance, Healthcare Costs, Payment, Surgery
Ferranna M, Robinson LA, Cadarette D
The benefits and costs of U.S. employer COVID-19 vaccine mandates.
This study examined the benefits and costs of U.S. employer COVID-19 mandates for federal employees and contractors and for some healthcare and private sector workers if there had not been major challenges in court that halted or delayed the mandates. The authors estimated the direct costs and health-related benefits that would have accrued if these vaccination requirements had been implemented as intended. Compared with the January 2022 vaccination rates, they found that the mandates could have led to 15 million additional vaccinated individuals, increasing the overall proportion of the fully vaccinated U.S. population from 64% to 68%. They examined scenarios involving the emergence of a novel, more transmissible variant, against which vaccination and previous infection offer moderate protection, and found that the estimated net benefits are potentially large. They estimated that they reach almost $20,000 per additional vaccinated individual, with more than 20,000 total deaths averted over the 6-month period assessed. For other scenarios involving a fading pandemic, existing vaccination-acquired or infection-acquired immunity provides sufficient protection, and the mandates' benefits are unlikely to exceed their costs. They believe that mandates may be most useful when the consequences of inaction are catastrophic. However, they did not compare the effects of mandates with alternative policies for increasing vaccination rates or for promoting other protective measures, which may receive stronger public support and be less likely to be overturned by litigation.
AHRQ-funded; HS000055.
Citation: Ferranna M, Robinson LA, Cadarette D .
The benefits and costs of U.S. employer COVID-19 vaccine mandates.
Risk Anal 2023 Oct; 43(10):2053-68. doi: 10.1111/risa.14090..
Keywords: COVID-19, Vaccination, Healthcare Costs
Mellor JM, McInerney M, Garrow RC
The impact of Medicaid expansion on spending and utilization by older low-income Medicare beneficiaries.
This study examined indirect spillover effects of Affordable Care Act (ACA) Medicaid expansions to working-age adults on health care coverage, spending, and utilization by older low-income Medicare beneficiaries. The authors used data from the 2010-2018 Health and Retirement Study survey linked to annual Medicare beneficiary summary files. They estimated individual-level difference-in-differences models of total spending for inpatient, institutional outpatient, physician/professional provider services; inpatient stays, outpatient visits, physician visits; and Medicaid and Part A and B Medicare coverage. They also compared changes in outcomes before and after Medicaid expansion in expansion versus nonexpansion states. The sample included low-income respondents aged 69 and older with linked Medicare data, enrolled in full-year traditional Medicare, and living in the community. ACA Medicaid expansion was associated with a 9.8 percentage point increase in Medicaid coverage, a 4.4 percentage point increase in having any institutional outpatient spending, and a positive but statistically insignificant 2.4 percentage point change in Part B enrollment.
AHRQ-funded; HS025422.
Citation: Mellor JM, McInerney M, Garrow RC .
The impact of Medicaid expansion on spending and utilization by older low-income Medicare beneficiaries.
Health Serv Res 2023 Oct; 58(5):1024-34. doi: 10.1111/1475-6773.14155..
Keywords: Medicaid, Medicare, Low-Income, Healthcare Utilization, Healthcare Costs, Health Insurance
Jazowski SA, Vaidya AU, Donohue JM
Commercial health plan and enrollee out-of-pocket spending on accelerated approval products in 2019.
Accelerated approval products, including those of low or uncertain therapeutic value, have cost Medicare and Medicaid billions of dollars annually. The financial implications of this program for commercial payers is unknown. The purpose of this study was to estimate health plan and out-of-pocket spending on product indication pairs (products provided accelerated approval for specific indications) that did and did not confirm clinical benefit. The study found that commercial health plan spending on 93 product indication pairs totaled $1.3 billion in 2019. When this amount was extrapolated to all US ESI plans, the total equaled $9.0 billion. Health plans spent over double on product-indication pairs converted to full approval based on surrogate end points when compared to those based on clinical end points. Health plan expenditures on product-indication pairs not yet converted to full approval equaled $261.9 million ($1.9 billion for all US ESI plans). Sixty-nine percent of that amount was ascribed to those with post-marketing studies within FDA deadlines. Out-of-pocket spending totaled $17.5million, or $125.5 million for all US ESI enrollees. Fewer than one-fifth of enrollees pending was on product-indication pairs converted to full approval based on clinical end points. Of the $5.9 million spent on product-indication pairs not yet converted to full approval, 46%was ascribed to those with post-marketing studies within FDA deadlines.
AHRQ-funded; HS026122.
Citation: Jazowski SA, Vaidya AU, Donohue JM .
Commercial health plan and enrollee out-of-pocket spending on accelerated approval products in 2019.
JAMA Intern Med 2023 Sep; 183(9):1016-18. doi: 10.1001/jamainternmed.2023.2381..
Keywords: Health Insurance, Healthcare Costs
Eddelbuettel JCP, Barry CL, Kennedy-Hendricks A
High-deductible health plans and nonfatal opioid overdose.
This study examined whether an employer offering a high-deductible health plan (HDHP) had an impact on nonfatal opioid overdose among commercially insured individuals with opioid use disorder (OUD) in the United States. The authors used deidentified insurance claims data from 2007 to 2017 with 97,788 person-years. They estimated the change in the probability of a nonfatal opioid overdose among enrollees with OUD whose employers began offering an HDHP insurance option during the study period compared with the change among those whose employer never offered an HDHP. Across both groups, 2% of the sample experienced a nonfatal opioid overdose during the study period. They found no association of HDHP with an observed increase in the probability of nonfatal opioid overdose among commercially insured person-years with OUD.
AHRQ-funded; HS000029.
Citation: Eddelbuettel JCP, Barry CL, Kennedy-Hendricks A .
High-deductible health plans and nonfatal opioid overdose.
Med Care 2023 Sep; 61(9):601-04. doi: 10.1097/mlr.0000000000001886..
Keywords: Healthcare Costs, Health Insurance, Opioids, Substance Abuse, Behavioral Health
Anderson KE, DiStefano MJ, Liu A
Incorporating added therapeutic benefit and domestic reference pricing into Medicare payment for expensive part B drugs.
The objective of this retrospective analysis was to identify expensive Part B drugs and to consider the evidence for each drug's added benefit in order to model a reimbursement policy for Medicare that integrates added benefit assessment and domestic reference pricing. Data were taken from a nationally representative sample of traditional Medicare Part B claims. The analysis showed that more than one-third of the expensive Part B drugs prescribed in 2019 offered low added benefit. The authors concluded that reference pricing based on added benefit assessment could be used to address the launch prices for expensive Part B drugs with low added benefit.
AHRQ-funded; HS000029.
Citation: Anderson KE, DiStefano MJ, Liu A .
Incorporating added therapeutic benefit and domestic reference pricing into Medicare payment for expensive part B drugs.
Value Health 2023 Sep; 26(9):1381-88. doi: 10.1016/j.jval.2023.05.018..
Keywords: Medicare, Payment, Medication, Healthcare Costs
Landon BE, Lam MB, Landrum MB
Opportunities for savings in risk arrangements for oncologic care.
High spending for cancer care is a target for savings as the United States hastens adoption of alternative payment through global payment models such as Accountable Care Organizations (ACOs) or Medicare Advantage (MA). The purpose of this study was to quantify the level at which Accountable Care Organizations ACOs and other risk-bearing organizations operating in a specific geographic area could realize savings by directing patients to efficient medical oncology practices. The incident cohort included 1,309,825 patients Options for directing differed across markets; the top quartile market had 10 or more oncology practices, but the bottom quartile had 3 or fewer oncology practices. Total spending (including Medicare Part D) in the incident cohort increased from a mean of $57,314 in 2009 to 2010 to $66,028 in 2016 to 2017. Within markets, total spending for practices in the highest spending quartile was 19% greater than in the lowest quartile. Hospital spending was the single largest component of spending in both time periods followed by Part B (infused) chemotherapy. Correlations in practice-level spending between the first-year (2009) and second-year (2010) spending were high.
Citation: Landon BE, Lam MB, Landrum MB .
Opportunities for savings in risk arrangements for oncologic care.
JAMA Health Forum 2023 Sep; 4(9):e233124. doi: 10.1001/jamahealthforum.2023.3124..
Keywords: Cancer, Medicare, Healthcare Costs, Payment
MacDougall H, Hanson S, Interrante JD
Rural-urban differences in health care unaffordability during the postpartum period.
The purpose of this cross-sectional study was to explore health care unaffordability for rural and urban residents and by postpartum status. The study found that postpartum people reported statistically significantly higher rates of inability to pay medical bills when compared with non-postpartum people. Rural residents also reported higher rates of inability to pay their medical bills and having problems paying medical bills as compared with urban residents. In adjusted models, the predicted probability of being unable to pay medical bills among postpartum respondents was 12.8%, which was higher than among non-postpartum respondents. Similarly, postpartum respondents had higher predicted probabilities of reporting problems paying medical bills (18.4%) than compared with non-postpartum respondents. IN adjusted models, residency in a rural area was not significantly related with the health care unaffordability outcome measures.
AHRQ-funded; HS000011.
Citation: MacDougall H, Hanson S, Interrante JD .
Rural-urban differences in health care unaffordability during the postpartum period.
Med Care 2023 Sep; 61(9):595-600. doi: 10.1097/mlr.0000000000001888..
Keywords: Rural Health, Urban Health, Rural/Inner-City Residents, Maternal Care, Healthcare Costs, Women, Access to Care
Tummalapalli SL, Struthers SA, White D
Optimal care for kidney health: development of a Merit-based Incentive Payment System (MIPS) value pathway.
This article detailed the iterative consensus-building process used by the American Society of Nephrology Quality Committee to develop the Optimal Care for Kidney Health Merit-based Incentive Payment System (MIPS) Value Pathway (MVP). The Optimal Care for Kidney Health MVP, published in the 2023 Medicare Physician Fee Schedule Final Rule, included measures related to angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use, hypertension control, readmissions, acute kidney injury requiring dialysis, and advance care planning. The MVP nephrology’s goal was to streamline measure selection in MIPS and served as a case study of collaborative policymaking between one professional organization and national regulatory agencies.
AHRQ-funded; HS028684.
Citation: Tummalapalli SL, Struthers SA, White D .
Optimal care for kidney health: development of a Merit-based Incentive Payment System (MIPS) value pathway.
J Am Soc Nephrol 2023 Aug; 34(8):1315-28. doi: 10.1681/asn.0000000000000163..
Keywords: Kidney Disease and Health, Payment, Healthcare Costs, Medicare
Decker SL, Zuvekas SH
AHRQ Author: Decker SL, Zuvekas SH
Primary care spending in the US population.
This AHRQ-authored research letter describes an analysis of primary care spending estimates in the US population using MEPS data. This survey study looked at the entire population, regardless of insurance source. The authors reported 2019 estimates of primary care spending, total medical spending, percentage of medical spending on primary care visits, and percentage with 0 spending on primary care visits. They analyzed race and ethnicity data to test whether primary care spending was greater in some groups compared with others. A total of 28,512 MEPS participants were included in the sample with a mean age of 38.6 and weighted percentages of 51.1% female, 18.5% Hispanic, 12.3% non-Hispanic Black, 59.7% non-Hispanic White, and 9.6% non-Hispanic individuals of other races and ethnicities. Primary care spending totaled $439 per person in 2019. Spending was highest for the Medicare population, Hispanics (52.7%), non-Hispanic Black (49.0%), and non-Hispanic other (44.3%), 79.9% for uninsured individuals and lowest for the uninsured. Average spending was $461 for those with group private insurance. The percentage of medical spending on primary care was 7.0% for the population and was lower for those younger than age 65 (5.1%), those in worse health (5.6%), and those with Medicare (5.3%). Almost 41% of the population had no primary care spending.
AHRQ-authored.
Citation: Decker SL, Zuvekas SH .
Primary care spending in the US population.
JAMA Intern Med 2023 Aug; 183(8):880-81. doi: 10.1001/jamainternmed.2023.1551..
Keywords: Medical Expenditure Panel Survey (MEPS), Healthcare Costs, Primary Care
Sharma H, Xu L
Use of intergovernmental transfers-based Medicaid supplemental payments to boost nursing home finances: evidence from Indiana nursing homes.
The objective of this study was to estimate the effect of participation in the intergovernmental transfers-based Medicaid supplemental payment program on nursing home revenue and expenditures. Data was taken from all Medicare and Medicaid-certified nursing homes in Indiana from 2009-17. The findings indicated that nursing homes owned or operated by nonstate governmental organizations received a fraction of the total supplemental payments on average, but the authors observed increased payments in later years. Participating nursing homes did not increase clinical expenses. The authors concluded that these findings raised questions regarding the transparency of financing arrangements between nonstate governmental organizations and nursing homes and the need to link supplemental payments to clinical expenses.
AHRQ-funded; HS027235.
Citation: Sharma H, Xu L .
Use of intergovernmental transfers-based Medicaid supplemental payments to boost nursing home finances: evidence from Indiana nursing homes.
Med Care 2023 Aug; 61(8):546-53. doi: 10.1097/mlr.0000000000001875..
Keywords: Nursing Homes, Medicare, Medicaid, Healthcare Costs
Ganguli I, Crawford ML, Usadi B
Who's accountable? Low-value care received by Medicare beneficiaries outside of their attributed health systems.
This study examined where and from whom Medicare beneficiaries aged 65 and older received forty low-value services during 2017-18 and identified factors associated with out-of-system receipt. The authors used national Medicare data for fee-for-service beneficiaries aged sixty-five and older and attributed to 595 US health systems for 2017 and 2018. Almost half (43%) of low-value services received by attributed beneficiaries originated from out-of-system clinicians: 38 percent from specialists, 4 percent from primary care physicians, and 1 percent from advanced practice clinicians. Recipients of low-value care were more likely to obtain care out of system if age 75 or older, male, non-Hispanic white, rural dwelling, more medically complex, or experiencing lower continuity of care. Out-of-system receipt was not associated with recipients' health systems' accountable care organization status.
AHRQ-funded; HS024075.
Citation: Ganguli I, Crawford ML, Usadi B .
Who's accountable? Low-value care received by Medicare beneficiaries outside of their attributed health systems.
Health Aff 2023 Aug; 42(8):1128-39. doi: 10.1377/hlthaff.2022.01319..
Keywords: Medicare, Healthcare Costs
Hill SC, Jacobs PD, Johnson CA
AHRQ Author: Hill SC, Jacobs PD
Availability of off-marketplace plans with lower premiums for higher-income families.
Prior to 2021, families with incomes above 400% of the federal poverty level were ineligible for marketplace premium tax credits and may again be after 2025. This income cap was temporarily removed by current laws, but some higher-income families still receive zero tax credits because credits limit out-of-pocket premiums for a reference plan as a portion of income. The purpose of this study was to quantify 2 variables: 1) premium variations between on- and off-marketplace plans and 2) the relationship between these premium variations and state decisions to finance cost-sharing reductions (CSRs) for lower-income families. The researchers developed a comprehensive database of on- and off-marketplace plans in each county and compared on- and off-marketplace plan premiums in 2020 and the rates of growth in the numbers of plans. The study found that in 2020, 89% of the United States population lived in counties with an availability of plans offered only off-marketplace. In those counties premiums for the lowest-cost off-marketplace plans averaged 11.3% less than premiums for the lowest-cost on-marketplace plans. In comparison the lowest-cost off-marketplace plans were more expensive on average. Silver plan premiums were 6.1% higher off-marketplace than on-marketplace in states that loaded CSRs on all silver plans, and 13.5% lower in states that loaded CSRs only on on-marketplace silver plans.
AHRQ-authored.
Citation: Hill SC, Jacobs PD, Johnson CA .
Availability of off-marketplace plans with lower premiums for higher-income families.
Am J Manag Care 2023 Jul; 29(7):371-76. doi: 10.37765/ajmc.2023.89397..
Keywords: Health Insurance, Healthcare Costs